You just read:

Capricor Therapeutics to Report Six-Month Results from the Randomized Phase I/II HOPE Clinical Trial in Duchenne Muscular Dystrophy

News provided by

Capricor Therapeutics, Inc.

24 Apr, 2017, 16:30 ET